跳至主要内容
临床试验/NCT04051216
NCT04051216已完成不适用

The SMART CART Study: Health Information Technology

University of Michigan Rogel Cancer Center2 个研究点 分布在 1 个国家目标入组 148 人开始时间: 2017年12月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
148
试验地点
2
主要终点
Percentage of caregivers that log onto the BMT Roadmap at least once per day for a minimum of 4 of the 7 days of the week while the patient is in the hospital.

研究概览

简要总结

This study evaluates the feasibility of using two information technology tools in patients undergoing Chimeric Antigen Receptor T-cell (CART) therapy and other Cytokine Release Syndrome (CRS)-eliciting treatments such as CD123 BITE. The first is an Apple iPad® application called the BMT Roadmap, which shows information about the participant's health. The second is a wearable activity monitoring device. Health information technology tools such as Roadmap system and the activity monitoring device may enable caregivers and patients to become more active participants in their healthcare.

详细描述

100 patients will be asked to participate in the wearable device portion of the study. 100 caregivers will be asked to participate in the Roadmap (iPad) portion of the study.

Each caregiver will be provided with an iPad to use the BMT Roadmap system. Patients and/or caregivers are free to use this tool as much as they would like on their own time while in the hospital. The hospital care team will collect the iPad when the patient is discharged and ready to go home. Patients and caregivers will also be asked to take three surveys that will ask about their feelings and thoughts about the Roadmap application. The surveys will be completed when patients are admitted for their CART or other CRS-eliciting therapy, when they get discharged from the hospital and around 100 days after they receive their therapy.

In addition to the use of the BMT Roadmap, this study will include around 7-10 interviews about participants' opinions on the two tools and their experience in the therapy process.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
3 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Percentage of caregivers that log onto the BMT Roadmap at least once per day for a minimum of 4 of the 7 days of the week while the patient is in the hospital.

时间窗: Duration of hospital admission, up to ~6 weeks

To test the feasibility of implementing the system in the pediatric CART population. This aim will be measured quantitatively by the log-use data.

次要结局

  • Percentage of patients who are able to wear the activity monitoring device(s) approximately 12 hours of the day.(Up to day 100 post-CART)
  • Quality of care process redesign associated with the Roadmap information system and wearable monitoring devices.(Up to day 100 post-CART)
  • Caregiver activation/participation compared to reference population to measure the impact of Roadmap information system and wearable monitoring device using survey instrument scores of Parent-Patient Activation Measure (P-PAM) as a composite measure.(Up to day 100 post-CART)
  • Percentage of patients from whom longitudinal samples of blood, urine and stool are collected, for correlative studies.(Up to day 100 post-CART)
  • Care providers' satisfaction with the Roadmap information system and non-invasive, wearable activity monitoring device health IT tools for patients and their families/caregivers.(Up to day 100 post-CART)
  • Presence of care process redesign associated with the Roadmap information system and wearable monitoring devices.(Up to day 100 post-CART)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验